🔎 Trials Near Me

ホーム › COPD › フロリダ州

フロリダ州におけるCOPDの臨床試験

フロリダ州内の拠点で、COPDに関する28件の研究が参加者を募集しています。

フロリダ州内の都市

公式研究テキスト(英語)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Meris Clinical Research- Site Number : 8400153, Brandon
  • Hillcrest Medical Research- Site Number : 8400082, DeLand
  • Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
  • 他18件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  • International Clinical Research, Altamonte Springs
  • Nature Coast Clinical Research, Crystal River
  • Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
  • 他2件
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Millennium Medical Research - Miami, Miami
  • Deluxe Health Center, Miami Lakes
  • Florida Institute For Clinical Research, LLC, Orlando
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  • GSK Investigational Site, Miami
  • GSK Investigational Site, Tampa
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/25更新 · NCT07780656

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
被験者募集中第4相
40歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Helix Biomedics- Site Number : 8400065, Boynton Beach
  • Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
  • Eastern Medical Group Research- Site Number : 8400020, Fort Myers
  • 他10件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

  • Helix Biomedics- Site Number : 8403065, Boynton Beach
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/21更新 · NCT07793409

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Orlando Health, Orlando
被験者募集中
40歳〜80歳 · 全性別 · 2026/09/17更新 · NCT06035120

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

  • WB Contracted Clinical Research Site, Miami Lakes
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07646587

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Brandon
  • Research Site, Cape Coral
  • Research Site, Clearwater
  • 他17件
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  • GSK Investigational Site, Doral
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/09更新 · NCT07780669

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Florida, Jacksonville
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Bay Pines
  • Research Site, Boynton Beach
  • Research Site, Jacksonville
  • 他5件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Clearwater
  • Research Site, Cutler Bay
  • Research Site, Cutler Bay
  • 他9件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Finlay Medical Research, Greenacres City
  • Clinical Research Specialists LLC, Kissimmee
  • Advanced Pulmonary Research Institute, Loxahatchee Groves
  • 他9件
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/08/27更新 · NCT07705737

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Boynton Beach
  • Research Site, Bradenton
  • Research Site, Cape Coral
  • 他25件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966

Alpha-1 Research Registry

  • Alpha-1 Foundation, Coral Gables
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/19更新 · NCT04157049

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 103, Gainesville
  • GC2501 Study Site 105, Miami
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/11更新 · NCT07555483

STRIVE Post-Market Registry Study

  • University of Miami, Coral Gables
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Brandon
  • GSK Investigational Site, Crystal River
  • GSK Investigational Site, Doral
  • 他8件
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

  • University of Miami, Miami
被験者募集中
18歳〜100歳 · 全性別 · 2026/06/22更新 · NCT06578156

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  • Mayo Clinic Jacksonville, Jacksonville
被験者募集中
40歳〜80歳 · 全性別 · 2026/04/28更新 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  • Mayo Clinic, Jacksonville
  • Orlando Health, Orlando
被験者募集中
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Brooksville
  • GSK Investigational Site, Doral
  • GSK Investigational Site, Fort Lauderdale
  • 他15件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

  • GSK Investigational Site, Loxahatchee Groves
  • GSK Investigational Site, Miami
被験者募集中第3相
40歳〜80歳 · 全性別 · 2025/10/08更新 · NCT06959095

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Hillcrest Medical Research, DeLand
  • Universal Axon Clinical Research, Doral
  • I.H.S Health, LLC, Kissimmee
  • 他3件
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • University of Florida, Jacksonville, Jacksonville
  • Alloy Clinical Research, Kissimmee
  • Reliable Research, Inc., Miami
  • 他2件
被験者募集中
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。